Gyongyi Szabo
Concepts (509)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ethanol | 52 | 2016 | 238 | 14.630 |
Why?
| MicroRNAs | 30 | 2017 | 427 | 10.380 |
Why?
| Hepacivirus | 31 | 2015 | 87 | 9.520 |
Why?
| Liver Diseases, Alcoholic | 23 | 2017 | 40 | 8.410 |
Why?
| Liver | 37 | 2015 | 542 | 8.130 |
Why?
| Monocytes | 28 | 2015 | 299 | 6.820 |
Why?
| Hepatocytes | 21 | 2017 | 100 | 6.340 |
Why?
| Hepatitis C | 22 | 2015 | 102 | 6.160 |
Why?
| Hepatitis C, Chronic | 20 | 2015 | 62 | 5.870 |
Why?
| Liver Diseases | 13 | 2013 | 95 | 5.420 |
Why?
| Fatty Liver | 14 | 2016 | 68 | 5.270 |
Why?
| Toll-Like Receptor 4 | 24 | 2014 | 300 | 4.950 |
Why?
| Dendritic Cells | 20 | 2013 | 383 | 4.670 |
Why?
| Fatty Liver, Alcoholic | 10 | 2015 | 19 | 4.410 |
Why?
| Immunity, Innate | 19 | 2015 | 539 | 4.020 |
Why?
| Alcohol Drinking | 15 | 2015 | 198 | 3.840 |
Why?
| Exosomes | 7 | 2015 | 17 | 3.790 |
Why?
| Signal Transduction | 29 | 2015 | 2304 | 3.710 |
Why?
| Lipopolysaccharides | 28 | 2015 | 516 | 3.640 |
Why?
| Liver Neoplasms | 12 | 2015 | 182 | 3.640 |
Why?
| Animals | 90 | 2017 | 14706 | 3.270 |
Why?
| Tumor Necrosis Factor-alpha | 24 | 2015 | 489 | 3.090 |
Why?
| Inflammation | 17 | 2015 | 666 | 2.880 |
Why?
| Macrophages | 11 | 2015 | 729 | 2.860 |
Why?
| Hepatitis, Alcoholic | 6 | 2016 | 11 | 2.780 |
Why?
| Liver Cirrhosis | 8 | 2015 | 81 | 2.740 |
Why?
| Carcinoma, Hepatocellular | 9 | 2015 | 97 | 2.620 |
Why?
| Toll-Like Receptors | 14 | 2013 | 423 | 2.610 |
Why?
| Humans | 117 | 2017 | 34161 | 2.480 |
Why?
| Cytokines | 25 | 2015 | 719 | 2.450 |
Why?
| Alcoholism | 11 | 2015 | 168 | 2.420 |
Why?
| Mice, Inbred C57BL | 29 | 2015 | 2283 | 2.390 |
Why?
| Mice | 44 | 2017 | 7381 | 2.370 |
Why?
| Interferon-alpha | 10 | 2013 | 93 | 2.300 |
Why?
| NF-kappa B | 16 | 2014 | 386 | 2.290 |
Why?
| Toll-Like Receptor 2 | 15 | 2010 | 234 | 2.250 |
Why?
| Immune System | 6 | 2015 | 98 | 2.050 |
Why?
| Interleukin-10 | 9 | 2015 | 128 | 2.040 |
Why?
| Hepatitis | 5 | 2013 | 39 | 2.010 |
Why?
| Viral Core Proteins | 8 | 2008 | 34 | 2.010 |
Why?
| Up-Regulation | 12 | 2016 | 322 | 1.820 |
Why?
| Myeloid Cells | 6 | 2012 | 55 | 1.810 |
Why?
| Central Nervous System Depressants | 6 | 2015 | 30 | 1.800 |
Why?
| Myeloid Differentiation Factor 88 | 5 | 2014 | 197 | 1.760 |
Why?
| Gene Expression Regulation | 9 | 2016 | 1217 | 1.750 |
Why?
| Female | 57 | 2017 | 18882 | 1.730 |
Why?
| Interleukin-1beta | 10 | 2015 | 183 | 1.700 |
Why?
| Virus Replication | 8 | 2015 | 242 | 1.680 |
Why?
| Interferon Type I | 5 | 2013 | 106 | 1.620 |
Why?
| Interferon-gamma | 7 | 2013 | 497 | 1.550 |
Why?
| Endotoxins | 4 | 2014 | 59 | 1.550 |
Why?
| Carrier Proteins | 7 | 2015 | 615 | 1.550 |
Why?
| Lipid Metabolism | 6 | 2015 | 136 | 1.440 |
Why?
| Disease Models, Animal | 16 | 2017 | 1190 | 1.420 |
Why?
| Leukocytes, Mononuclear | 6 | 2015 | 214 | 1.410 |
Why?
| Mice, Knockout | 16 | 2015 | 1607 | 1.390 |
Why?
| Viral Nonstructural Proteins | 5 | 2007 | 55 | 1.360 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 4 | 2015 | 15 | 1.340 |
Why?
| Cell Differentiation | 8 | 2015 | 1046 | 1.300 |
Why?
| Inflammation Mediators | 7 | 2015 | 134 | 1.300 |
Why?
| Uric Acid | 2 | 2015 | 39 | 1.280 |
Why?
| Cell Communication | 6 | 2015 | 99 | 1.280 |
Why?
| Intestines | 3 | 2014 | 132 | 1.260 |
Why?
| RNA, Viral | 4 | 2014 | 196 | 1.260 |
Why?
| Kupffer Cells | 11 | 2015 | 32 | 1.260 |
Why?
| Killer Cells, Natural | 6 | 2015 | 190 | 1.240 |
Why?
| Methionine | 7 | 2015 | 43 | 1.220 |
Why?
| Transcription Factors | 6 | 2017 | 1200 | 1.200 |
Why?
| Disease Progression | 9 | 2015 | 479 | 1.190 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 21 | 1.180 |
Why?
| Adenosine Triphosphate | 2 | 2015 | 229 | 1.160 |
Why?
| Hypoxia-Inducible Factor 1 | 2 | 2014 | 10 | 1.150 |
Why?
| Receptors, Cell Surface | 5 | 2015 | 442 | 1.100 |
Why?
| Choline Deficiency | 6 | 2014 | 13 | 1.080 |
Why?
| Cells, Cultured | 14 | 2015 | 1799 | 1.080 |
Why?
| DNA-Binding Proteins | 4 | 2017 | 1007 | 1.060 |
Why?
| Interferon Regulatory Factor-3 | 2 | 2013 | 75 | 1.060 |
Why?
| Cytoskeletal Proteins | 2 | 2013 | 134 | 1.050 |
Why?
| Research | 2 | 2015 | 138 | 1.000 |
Why?
| RNA, Messenger | 11 | 2014 | 1255 | 0.990 |
Why?
| Alcohols | 2 | 2014 | 12 | 0.980 |
Why?
| Macrophage Activation | 4 | 2015 | 100 | 0.980 |
Why?
| Male | 32 | 2017 | 17243 | 0.970 |
Why?
| Acetaminophen | 4 | 2015 | 39 | 0.950 |
Why?
| Membrane Glycoproteins | 4 | 2005 | 623 | 0.940 |
Why?
| Apoptosis | 9 | 2013 | 868 | 0.940 |
Why?
| Caspase 1 | 4 | 2014 | 68 | 0.930 |
Why?
| Case-Control Studies | 8 | 2017 | 660 | 0.930 |
Why?
| Membrane Proteins | 3 | 2015 | 650 | 0.920 |
Why?
| Gastrointestinal Tract | 3 | 2011 | 89 | 0.890 |
Why?
| T-Lymphocytes, Regulatory | 3 | 2012 | 123 | 0.890 |
Why?
| Blotting, Western | 8 | 2014 | 538 | 0.860 |
Why?
| Membrane Microdomains | 3 | 2013 | 43 | 0.840 |
Why?
| Liver Neoplasms, Experimental | 2 | 2016 | 22 | 0.840 |
Why?
| Chemokine CCL2 | 6 | 2014 | 54 | 0.810 |
Why?
| Hepatitis C Antibodies | 3 | 2012 | 9 | 0.800 |
Why?
| Adult | 22 | 2017 | 9698 | 0.800 |
Why?
| Toll-Like Receptor 9 | 4 | 2014 | 155 | 0.800 |
Why?
| Middle Aged | 24 | 2017 | 9874 | 0.800 |
Why?
| Vimentin | 2 | 2015 | 15 | 0.790 |
Why?
| T-Lymphocytes | 5 | 2008 | 898 | 0.780 |
Why?
| Brain | 3 | 2014 | 849 | 0.780 |
Why?
| STAT3 Transcription Factor | 2 | 2008 | 36 | 0.780 |
Why?
| Reperfusion Injury | 2 | 2015 | 36 | 0.770 |
Why?
| Granuloma | 2 | 2008 | 30 | 0.760 |
Why?
| Gene Expression Profiling | 4 | 2015 | 479 | 0.750 |
Why?
| Alanine Transaminase | 5 | 2015 | 31 | 0.720 |
Why?
| RNA, Neoplasm | 1 | 2016 | 32 | 0.690 |
Why?
| Anti-Infective Agents, Local | 2 | 2013 | 19 | 0.690 |
Why?
| Adaptor Proteins, Signal Transducing | 4 | 2012 | 287 | 0.690 |
Why?
| Antigen-Presenting Cells | 3 | 2008 | 158 | 0.690 |
Why?
| Neutralization Tests | 3 | 2014 | 122 | 0.690 |
Why?
| HSP90 Heat-Shock Proteins | 2 | 2014 | 48 | 0.680 |
Why?
| Interleukins | 2 | 2012 | 64 | 0.680 |
Why?
| Cell Line | 8 | 2015 | 1755 | 0.680 |
Why?
| Antigens, CD14 | 6 | 2008 | 150 | 0.680 |
Why?
| Liver Cirrhosis, Alcoholic | 2 | 2015 | 9 | 0.670 |
Why?
| Probenecid | 1 | 2015 | 6 | 0.670 |
Why?
| Allopurinol | 1 | 2015 | 16 | 0.670 |
Why?
| Lymphocyte Antigen 96 | 3 | 2011 | 55 | 0.660 |
Why?
| Cell Polarity | 1 | 2015 | 89 | 0.650 |
Why?
| Diet | 4 | 2015 | 460 | 0.640 |
Why?
| Gene Expression | 4 | 2015 | 611 | 0.630 |
Why?
| NADPH Oxidase | 2 | 2012 | 78 | 0.620 |
Why?
| Immunocompromised Host | 1 | 2015 | 57 | 0.620 |
Why?
| RNA Stability | 2 | 2015 | 70 | 0.620 |
Why?
| Neoplasm Proteins | 1 | 2016 | 225 | 0.620 |
Why?
| RNA, Ribosomal, 16S | 1 | 2014 | 29 | 0.610 |
Why?
| Inflammatory Bowel Diseases | 1 | 2014 | 43 | 0.600 |
Why?
| Polymorphism, Genetic | 1 | 2014 | 168 | 0.590 |
Why?
| Immunity, Cellular | 3 | 2012 | 175 | 0.590 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 97 | 0.590 |
Why?
| Immune Tolerance | 2 | 2012 | 140 | 0.580 |
Why?
| Hepatitis B, Chronic | 1 | 2013 | 5 | 0.580 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 321 | 0.580 |
Why?
| Interleukin-12 | 2 | 2004 | 98 | 0.570 |
Why?
| Antiviral Agents | 6 | 2012 | 150 | 0.570 |
Why?
| Cell Line, Tumor | 6 | 2013 | 857 | 0.570 |
Why?
| Cerebellum | 1 | 2013 | 71 | 0.570 |
Why?
| Cell Transformation, Neoplastic | 2 | 2012 | 177 | 0.560 |
Why?
| Statistics, Nonparametric | 5 | 2014 | 175 | 0.560 |
Why?
| Cyclin G1 | 1 | 2012 | 1 | 0.560 |
Why?
| Interleukin-6 | 6 | 2014 | 231 | 0.560 |
Why?
| Forkhead Transcription Factors | 1 | 2013 | 83 | 0.560 |
Why?
| DNA, Bacterial | 1 | 2014 | 217 | 0.560 |
Why?
| Microfilament Proteins | 1 | 2013 | 83 | 0.550 |
Why?
| Pancreatitis, Alcoholic | 2 | 2015 | 3 | 0.550 |
Why?
| Microglia | 1 | 2013 | 81 | 0.540 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 166 | 0.540 |
Why?
| Phosphorylation | 5 | 2013 | 672 | 0.530 |
Why?
| Bone Marrow Cells | 2 | 2014 | 214 | 0.530 |
Why?
| Interleukin-1 Receptor-Associated Kinases | 2 | 2009 | 17 | 0.530 |
Why?
| Liver Regeneration | 1 | 2012 | 18 | 0.530 |
Why?
| Autoantigens | 1 | 2013 | 96 | 0.520 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 2012 | 402 | 0.500 |
Why?
| Metagenome | 1 | 2011 | 11 | 0.500 |
Why?
| Triglycerides | 4 | 2014 | 208 | 0.500 |
Why?
| Poly I-C | 1 | 2011 | 78 | 0.490 |
Why?
| Liver Cirrhosis, Experimental | 1 | 2011 | 3 | 0.490 |
Why?
| RNA, Double-Stranded | 1 | 2011 | 81 | 0.480 |
Why?
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2010 | 1 | 0.480 |
Why?
| Fatty Acids | 1 | 2011 | 134 | 0.470 |
Why?
| Receptors, Immunologic | 3 | 2007 | 155 | 0.470 |
Why?
| Proto-Oncogene Proteins | 1 | 2012 | 275 | 0.470 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 456 | 0.460 |
Why?
| Toll-Like Receptor 1 | 2 | 2007 | 27 | 0.460 |
Why?
| Gene Silencing | 1 | 2012 | 247 | 0.460 |
Why?
| Ligands | 5 | 2012 | 337 | 0.460 |
Why?
| Electrophoretic Mobility Shift Assay | 4 | 2014 | 56 | 0.450 |
Why?
| Time Factors | 6 | 2016 | 2605 | 0.450 |
Why?
| RNA-Binding Proteins | 1 | 2013 | 288 | 0.450 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 530 | 0.450 |
Why?
| Transcription Factor RelA | 2 | 2007 | 34 | 0.450 |
Why?
| Antibody Formation | 2 | 2006 | 103 | 0.440 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 103 | 0.440 |
Why?
| Toll-Like Receptor 7 | 1 | 2010 | 67 | 0.430 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2013 | 523 | 0.430 |
Why?
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 222 | 0.430 |
Why?
| Probiotics | 1 | 2009 | 13 | 0.430 |
Why?
| Down-Regulation | 3 | 2008 | 247 | 0.420 |
Why?
| Propionibacterium acnes | 2 | 2008 | 6 | 0.420 |
Why?
| Science | 1 | 2009 | 19 | 0.420 |
Why?
| Gastroenterology | 1 | 2009 | 22 | 0.420 |
Why?
| STAT1 Transcription Factor | 1 | 2008 | 18 | 0.410 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 10 | 0.410 |
Why?
| CHO Cells | 5 | 2007 | 186 | 0.410 |
Why?
| Receptors, Interleukin-1 | 2 | 2013 | 63 | 0.410 |
Why?
| Immunity | 2 | 2006 | 58 | 0.410 |
Why?
| RNA Virus Infections | 1 | 2008 | 1 | 0.400 |
Why?
| Leptin | 2 | 2005 | 54 | 0.400 |
Why?
| Autoimmunity | 1 | 2009 | 145 | 0.400 |
Why?
| DNA Virus Infections | 1 | 2008 | 8 | 0.400 |
Why?
| Cricetinae | 5 | 2007 | 401 | 0.390 |
Why?
| Toll-Like Receptor 6 | 1 | 2007 | 13 | 0.390 |
Why?
| Sp1 Transcription Factor | 1 | 2007 | 21 | 0.380 |
Why?
| I-kappa B Kinase | 1 | 2007 | 42 | 0.380 |
Why?
| Transcription Factor AP-1 | 1 | 2007 | 40 | 0.380 |
Why?
| Cell Culture Techniques | 1 | 2008 | 120 | 0.370 |
Why?
| src-Family Kinases | 1 | 2007 | 48 | 0.370 |
Why?
| Phenotype | 3 | 2015 | 803 | 0.370 |
Why?
| Mitochondria | 2 | 2005 | 202 | 0.360 |
Why?
| Systemic Inflammatory Response Syndrome | 2 | 2006 | 19 | 0.360 |
Why?
| Isoantigens | 2 | 2004 | 72 | 0.360 |
Why?
| Heme Oxygenase-1 | 1 | 2006 | 14 | 0.360 |
Why?
| Physicians | 1 | 2009 | 212 | 0.360 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 127 | 0.360 |
Why?
| Oxidative Stress | 4 | 2015 | 210 | 0.350 |
Why?
| Interleukin-1 | 3 | 2013 | 148 | 0.350 |
Why?
| Receptors, Pattern Recognition | 1 | 2006 | 27 | 0.350 |
Why?
| Actins | 3 | 2014 | 214 | 0.350 |
Why?
| Receptors, Glucocorticoid | 2 | 2002 | 17 | 0.350 |
Why?
| Protein Binding | 4 | 2015 | 1223 | 0.350 |
Why?
| T-Lymphocyte Subsets | 1 | 2008 | 229 | 0.340 |
Why?
| I-kappa B Proteins | 2 | 2002 | 35 | 0.340 |
Why?
| Propionibacterium | 1 | 2005 | 5 | 0.340 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2005 | 19 | 0.340 |
Why?
| HIV Infections | 1 | 2011 | 655 | 0.330 |
Why?
| Models, Biological | 4 | 2015 | 979 | 0.330 |
Why?
| Reactive Oxygen Species | 3 | 2013 | 163 | 0.320 |
Why?
| MAP Kinase Signaling System | 3 | 2015 | 149 | 0.320 |
Why?
| Adjuvants, Immunologic | 1 | 2006 | 194 | 0.320 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 152 | 0.320 |
Why?
| Antigen Presentation | 2 | 2004 | 180 | 0.310 |
Why?
| Antigens, Ly | 1 | 2004 | 46 | 0.310 |
Why?
| Clonal Anergy | 1 | 2004 | 25 | 0.310 |
Why?
| B-Lymphocytes | 1 | 2008 | 540 | 0.310 |
Why?
| Chronic Disease | 3 | 2013 | 536 | 0.310 |
Why?
| Viral Proteins | 3 | 2013 | 243 | 0.310 |
Why?
| Immunoprecipitation | 2 | 2014 | 118 | 0.290 |
Why?
| Polyethylene Glycols | 4 | 2012 | 119 | 0.290 |
Why?
| Growth Inhibitors | 1 | 2003 | 34 | 0.290 |
Why?
| Recombinant Proteins | 6 | 2012 | 612 | 0.290 |
Why?
| Energy Metabolism | 1 | 2005 | 263 | 0.290 |
Why?
| Permeability | 2 | 2014 | 33 | 0.280 |
Why?
| Feeding Behavior | 2 | 2015 | 248 | 0.280 |
Why?
| Coculture Techniques | 2 | 2013 | 76 | 0.280 |
Why?
| Immunosuppressive Agents | 1 | 2004 | 204 | 0.280 |
Why?
| Transforming Growth Factor beta | 3 | 2015 | 140 | 0.280 |
Why?
| Interleukin-2 | 1 | 2003 | 166 | 0.270 |
Why?
| Receptors, IgG | 1 | 2002 | 26 | 0.270 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 64 | 0.270 |
Why?
| Host-Pathogen Interactions | 2 | 2014 | 129 | 0.270 |
Why?
| Bacteria | 2 | 2014 | 133 | 0.270 |
Why?
| Flow Cytometry | 4 | 2012 | 615 | 0.270 |
Why?
| Cell Nucleus | 3 | 2015 | 494 | 0.270 |
Why?
| Collagen Type I | 2 | 2014 | 18 | 0.260 |
Why?
| Sex Factors | 2 | 2014 | 660 | 0.260 |
Why?
| Apoptosis Regulatory Proteins | 2 | 2013 | 114 | 0.260 |
Why?
| Dose-Response Relationship, Drug | 3 | 2008 | 694 | 0.250 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 270 | 0.250 |
Why?
| Insulin | 2 | 2015 | 564 | 0.240 |
Why?
| Sepsis | 1 | 2002 | 139 | 0.240 |
Why?
| Lymphocyte Culture Test, Mixed | 2 | 2012 | 28 | 0.240 |
Why?
| Interferon Regulatory Factor-7 | 2 | 2010 | 29 | 0.230 |
Why?
| Enzyme Inhibitors | 2 | 2015 | 279 | 0.230 |
Why?
| Matrix Metalloproteinase 2 | 2 | 2011 | 27 | 0.230 |
Why?
| Cholesterol | 2 | 2015 | 243 | 0.230 |
Why?
| Cell Proliferation | 3 | 2013 | 667 | 0.220 |
Why?
| Mitochondria, Liver | 2 | 2011 | 9 | 0.210 |
Why?
| Virus Diseases | 2 | 2015 | 107 | 0.210 |
Why?
| Viral Envelope Proteins | 3 | 2012 | 82 | 0.210 |
Why?
| Prognosis | 2 | 2014 | 937 | 0.200 |
Why?
| RNA | 2 | 2012 | 284 | 0.200 |
Why?
| Antibodies, Monoclonal | 2 | 2012 | 685 | 0.200 |
Why?
| Thiazoles | 2 | 2011 | 39 | 0.190 |
Why?
| RNA, Small Interfering | 2 | 2015 | 574 | 0.190 |
Why?
| Drosophila Proteins | 1 | 2002 | 621 | 0.190 |
Why?
| ROC Curve | 2 | 2015 | 145 | 0.180 |
Why?
| Cricetulus | 2 | 2007 | 75 | 0.180 |
Why?
| Adolescent | 5 | 2010 | 4026 | 0.180 |
Why?
| Diethylamines | 1 | 2016 | 2 | 0.180 |
Why?
| United States | 3 | 2010 | 4021 | 0.170 |
Why?
| Mannose-Binding Lectins | 1 | 2015 | 19 | 0.170 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2007 | 159 | 0.170 |
Why?
| Research Design | 2 | 2016 | 393 | 0.170 |
Why?
| Adjuvants, Pharmaceutic | 1 | 2015 | 3 | 0.170 |
Why?
| RNA Transport | 1 | 2015 | 29 | 0.170 |
Why?
| Biopsy | 3 | 2012 | 263 | 0.170 |
Why?
| Antimetabolites | 1 | 2015 | 13 | 0.170 |
Why?
| Smad3 Protein | 1 | 2015 | 8 | 0.170 |
Why?
| Choline | 1 | 2015 | 9 | 0.170 |
Why?
| Extracellular Space | 1 | 2015 | 21 | 0.170 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 19 | 0.170 |
Why?
| Lectins, C-Type | 1 | 2015 | 67 | 0.160 |
Why?
| Culture Media, Conditioned | 1 | 2015 | 44 | 0.160 |
Why?
| Terminology as Topic | 1 | 2016 | 103 | 0.160 |
Why?
| Organ Size | 1 | 2015 | 128 | 0.160 |
Why?
| Lymphocyte Activation | 2 | 2008 | 686 | 0.160 |
Why?
| Interleukin-18 | 1 | 2015 | 59 | 0.160 |
Why?
| Tissue Distribution | 1 | 2015 | 194 | 0.160 |
Why?
| Dietary Carbohydrates | 1 | 2015 | 70 | 0.160 |
Why?
| Phagocytosis | 1 | 2015 | 193 | 0.160 |
Why?
| Metabolic Syndrome X | 1 | 2016 | 107 | 0.160 |
Why?
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 3 | 0.160 |
Why?
| Immunophenotyping | 1 | 2015 | 167 | 0.160 |
Why?
| Procollagen | 1 | 2014 | 6 | 0.160 |
Why?
| Mice, Mutant Strains | 2 | 2005 | 283 | 0.160 |
Why?
| Microscopy, Confocal | 1 | 2015 | 191 | 0.160 |
Why?
| Bacterial Translocation | 1 | 2014 | 6 | 0.160 |
Why?
| Head and Neck Neoplasms | 1 | 2015 | 47 | 0.150 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2014 | 39 | 0.150 |
Why?
| Kidney | 2 | 2007 | 280 | 0.150 |
Why?
| Nuclear Proteins | 2 | 2012 | 695 | 0.150 |
Why?
| Bacterial Infections | 1 | 2015 | 85 | 0.150 |
Why?
| Liver Function Tests | 3 | 2009 | 30 | 0.150 |
Why?
| Acute-Phase Proteins | 1 | 2014 | 31 | 0.150 |
Why?
| Postoperative Complications | 2 | 2010 | 603 | 0.150 |
Why?
| Receptors, Virus | 1 | 2014 | 95 | 0.150 |
Why?
| Gene Deletion | 1 | 2015 | 234 | 0.150 |
Why?
| Dietary Sucrose | 1 | 2014 | 29 | 0.150 |
Why?
| Fructose | 1 | 2014 | 26 | 0.150 |
Why?
| Clinical Trials as Topic | 1 | 2016 | 309 | 0.150 |
Why?
| Nitric Oxide | 2 | 2005 | 112 | 0.140 |
Why?
| HMGB1 Protein | 1 | 2013 | 13 | 0.140 |
Why?
| Software | 1 | 2015 | 238 | 0.140 |
Why?
| Body Weight | 1 | 2015 | 348 | 0.140 |
Why?
| Peroxisome Proliferator-Activated Receptors | 2 | 2011 | 7 | 0.140 |
Why?
| Acetylation | 1 | 2013 | 98 | 0.140 |
Why?
| Hep G2 Cells | 1 | 2012 | 10 | 0.140 |
Why?
| Receptors, Interferon | 1 | 2012 | 12 | 0.140 |
Why?
| Weight Gain | 1 | 2014 | 153 | 0.140 |
Why?
| Receptors, Interleukin-1 Type I | 1 | 2012 | 7 | 0.140 |
Why?
| Gene Expression Regulation, Viral | 1 | 2012 | 42 | 0.140 |
Why?
| Interleukin-1alpha | 1 | 2012 | 18 | 0.140 |
Why?
| Cholestasis | 2 | 2002 | 39 | 0.140 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2012 | 10 | 0.130 |
Why?
| Regression Analysis | 1 | 2013 | 424 | 0.130 |
Why?
| Ribavirin | 1 | 2012 | 23 | 0.130 |
Why?
| Drug Evaluation, Preclinical | 1 | 2012 | 62 | 0.130 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 194 | 0.130 |
Why?
| Aspartate Aminotransferases | 1 | 2012 | 22 | 0.130 |
Why?
| Genetic Markers | 1 | 2012 | 106 | 0.130 |
Why?
| Protein-Tyrosine Kinases | 1 | 2013 | 137 | 0.130 |
Why?
| Microtubules | 1 | 2013 | 198 | 0.130 |
Why?
| Calcium-Binding Proteins | 1 | 2012 | 52 | 0.130 |
Why?
| Receptors, CCR2 | 1 | 2011 | 6 | 0.130 |
Why?
| Oligonucleotides, Antisense | 1 | 2012 | 60 | 0.130 |
Why?
| Immunohistochemistry | 1 | 2014 | 774 | 0.130 |
Why?
| Endocytosis | 1 | 2013 | 133 | 0.130 |
Why?
| Fibroblast Growth Factors | 1 | 2012 | 30 | 0.130 |
Why?
| Risk Factors | 3 | 2016 | 3030 | 0.130 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2012 | 43 | 0.130 |
Why?
| Metals | 1 | 2012 | 57 | 0.130 |
Why?
| Quinolines | 1 | 2011 | 23 | 0.130 |
Why?
| Activins | 1 | 2012 | 25 | 0.130 |
Why?
| Blood Glucose | 1 | 2014 | 385 | 0.130 |
Why?
| RNA Interference | 1 | 2015 | 499 | 0.130 |
Why?
| DNA Primers | 1 | 2012 | 302 | 0.130 |
Why?
| Toll-Like Receptor 8 | 1 | 2011 | 28 | 0.130 |
Why?
| Bone Marrow Transplantation | 1 | 2012 | 133 | 0.130 |
Why?
| Sleep Apnea, Obstructive | 1 | 2012 | 27 | 0.130 |
Why?
| Hepatitis B | 1 | 2011 | 23 | 0.120 |
Why?
| Insulin Resistance | 1 | 2014 | 309 | 0.120 |
Why?
| Disease | 1 | 2011 | 21 | 0.120 |
Why?
| Molecular Biology | 1 | 2011 | 47 | 0.120 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 8 | 0.120 |
Why?
| CpG Islands | 1 | 2012 | 173 | 0.120 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 10 | 0.120 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2011 | 45 | 0.120 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 93 | 0.120 |
Why?
| Lipid Peroxidation | 1 | 2011 | 60 | 0.120 |
Why?
| Embryonic Stem Cells | 1 | 2012 | 112 | 0.120 |
Why?
| Comorbidity | 2 | 2011 | 733 | 0.120 |
Why?
| Transforming Growth Factor beta1 | 1 | 2011 | 38 | 0.120 |
Why?
| Aged | 4 | 2017 | 7641 | 0.120 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2010 | 33 | 0.120 |
Why?
| Oxygen | 1 | 2012 | 208 | 0.120 |
Why?
| Analysis of Variance | 1 | 2012 | 531 | 0.120 |
Why?
| Young Adult | 2 | 2015 | 2167 | 0.120 |
Why?
| Collagen | 1 | 2011 | 119 | 0.120 |
Why?
| Esophageal and Gastric Varices | 1 | 2010 | 14 | 0.110 |
Why?
| Models, Animal | 1 | 2011 | 174 | 0.110 |
Why?
| History, 21st Century | 1 | 2010 | 83 | 0.110 |
Why?
| Dietary Fats | 1 | 2011 | 205 | 0.110 |
Why?
| Fibrosis | 1 | 2009 | 60 | 0.110 |
Why?
| History, 20th Century | 1 | 2010 | 172 | 0.110 |
Why?
| Base Sequence | 1 | 2012 | 1245 | 0.110 |
Why?
| Homeostasis | 1 | 2011 | 225 | 0.110 |
Why?
| Asthma | 1 | 2012 | 286 | 0.110 |
Why?
| Genotype | 1 | 2011 | 480 | 0.110 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 49 | 0.110 |
Why?
| Receptors, Cytokine | 1 | 2009 | 16 | 0.110 |
Why?
| Primates | 1 | 2009 | 28 | 0.110 |
Why?
| Knowledge | 1 | 2009 | 12 | 0.110 |
Why?
| Invertebrates | 1 | 2009 | 14 | 0.110 |
Why?
| Behavior | 1 | 2009 | 37 | 0.110 |
Why?
| Proteins | 1 | 2014 | 579 | 0.110 |
Why?
| Vertebrates | 1 | 2009 | 25 | 0.110 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2009 | 45 | 0.110 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2008 | 6 | 0.110 |
Why?
| NADP | 1 | 2008 | 15 | 0.110 |
Why?
| Mammals | 1 | 2009 | 76 | 0.100 |
Why?
| Chimera | 1 | 2008 | 39 | 0.100 |
Why?
| National Institutes of Health (U.S.) | 1 | 2009 | 58 | 0.100 |
Why?
| Dependovirus | 1 | 2012 | 324 | 0.100 |
Why?
| Career Choice | 1 | 2009 | 53 | 0.100 |
Why?
| Infection | 1 | 2008 | 58 | 0.100 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 53 | 0.100 |
Why?
| Biomedical Research | 1 | 2010 | 142 | 0.100 |
Why?
| Forecasting | 1 | 2009 | 161 | 0.100 |
Why?
| Herbal Medicine | 1 | 2008 | 3 | 0.100 |
Why?
| Hepatitis C Antigens | 1 | 2007 | 1 | 0.100 |
Why?
| Behavior, Animal | 1 | 2009 | 136 | 0.100 |
Why?
| Acute Disease | 1 | 2009 | 529 | 0.100 |
Why?
| Cell Separation | 1 | 2008 | 133 | 0.100 |
Why?
| Interferons | 1 | 2007 | 38 | 0.100 |
Why?
| Diagnosis, Differential | 1 | 2009 | 637 | 0.100 |
Why?
| Cell Movement | 2 | 2008 | 336 | 0.100 |
Why?
| Immunologic Factors | 1 | 2008 | 49 | 0.100 |
Why?
| Viruses | 1 | 2008 | 62 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2008 | 296 | 0.090 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 56 | 0.090 |
Why?
| Macrophages, Peritoneal | 1 | 2007 | 69 | 0.090 |
Why?
| Luminescent Proteins | 1 | 2007 | 123 | 0.090 |
Why?
| Leukopenia | 1 | 2006 | 13 | 0.090 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 115 | 0.090 |
Why?
| Cushing Syndrome | 1 | 2006 | 5 | 0.090 |
Why?
| Ketoconazole | 1 | 2006 | 6 | 0.090 |
Why?
| Cytoskeleton | 1 | 2007 | 121 | 0.090 |
Why?
| src Homology Domains | 1 | 2006 | 21 | 0.090 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2006 | 74 | 0.090 |
Why?
| Pituitary-Adrenal System | 1 | 2006 | 40 | 0.090 |
Why?
| Cytoplasm | 1 | 2007 | 230 | 0.090 |
Why?
| Membrane Fluidity | 1 | 2006 | 14 | 0.090 |
Why?
| Cell Survival | 2 | 2012 | 450 | 0.090 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2006 | 76 | 0.090 |
Why?
| Receptors, Scavenger | 1 | 2005 | 8 | 0.080 |
Why?
| Liver Failure, Acute | 1 | 2005 | 13 | 0.080 |
Why?
| Antifungal Agents | 1 | 2006 | 78 | 0.080 |
Why?
| Ischemic Preconditioning, Myocardial | 1 | 2005 | 23 | 0.080 |
Why?
| Enzyme Activation | 1 | 2006 | 329 | 0.080 |
Why?
| Cell Death | 1 | 2006 | 208 | 0.080 |
Why?
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 10 | 0.080 |
Why?
| Receptors, Leptin | 1 | 2005 | 12 | 0.080 |
Why?
| Mice, Obese | 1 | 2005 | 33 | 0.080 |
Why?
| Antigens, Differentiation | 1 | 2005 | 124 | 0.080 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2005 | 45 | 0.080 |
Why?
| Nitric Oxide Synthase | 1 | 2005 | 53 | 0.080 |
Why?
| Stress, Physiological | 1 | 2006 | 121 | 0.080 |
Why?
| Pneumonia | 1 | 2006 | 144 | 0.080 |
Why?
| DNA | 1 | 2008 | 608 | 0.080 |
Why?
| Atherosclerosis | 1 | 2006 | 111 | 0.080 |
Why?
| Tumor Suppressor Proteins | 1 | 2006 | 164 | 0.080 |
Why?
| Heart | 1 | 2005 | 211 | 0.070 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 2006 | 323 | 0.070 |
Why?
| Immunosuppression | 1 | 2003 | 80 | 0.070 |
Why?
| Carbon Monoxide | 1 | 2002 | 37 | 0.070 |
Why?
| Transfection | 1 | 2004 | 636 | 0.070 |
Why?
| NF-kappa B p50 Subunit | 1 | 2002 | 24 | 0.070 |
Why?
| Translocation, Genetic | 1 | 2002 | 53 | 0.070 |
Why?
| Cohort Studies | 1 | 2006 | 1417 | 0.070 |
Why?
| Heat-Shock Proteins | 1 | 2002 | 65 | 0.070 |
Why?
| Cross-Linking Reagents | 1 | 2002 | 91 | 0.070 |
Why?
| Response Elements | 1 | 2002 | 33 | 0.070 |
Why?
| Jurkat Cells | 1 | 2002 | 69 | 0.070 |
Why?
| Heat-Shock Response | 1 | 2002 | 21 | 0.070 |
Why?
| Treatment Outcome | 3 | 2016 | 2667 | 0.070 |
Why?
| Dexamethasone | 1 | 2002 | 85 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2002 | 50 | 0.060 |
Why?
| Hemodynamics | 1 | 2002 | 170 | 0.060 |
Why?
| Cell Division | 1 | 2003 | 431 | 0.060 |
Why?
| Hypoglycemic Agents | 1 | 2002 | 161 | 0.060 |
Why?
| Amino Acid Sequence | 2 | 2012 | 1491 | 0.050 |
Why?
| Obesity | 1 | 2004 | 871 | 0.050 |
Why?
| Length of Stay | 2 | 2010 | 400 | 0.040 |
Why?
| Endpoint Determination | 1 | 2016 | 23 | 0.040 |
Why?
| Consensus | 1 | 2016 | 51 | 0.040 |
Why?
| Th2 Cells | 2 | 2006 | 129 | 0.040 |
Why?
| Th1 Cells | 2 | 2006 | 128 | 0.040 |
Why?
| Pan troglodytes | 1 | 2012 | 33 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2016 | 893 | 0.030 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2011 | 3 | 0.030 |
Why?
| Acyl-CoA Oxidase | 1 | 2011 | 3 | 0.030 |
Why?
| Metabolomics | 1 | 2011 | 14 | 0.030 |
Why?
| Viral Load | 1 | 2012 | 169 | 0.030 |
Why?
| Drug Combinations | 1 | 2012 | 103 | 0.030 |
Why?
| Systems Biology | 1 | 2011 | 24 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2012 | 344 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2012 | 468 | 0.030 |
Why?
| Proteomics | 1 | 2011 | 125 | 0.030 |
Why?
| Liver Transplantation | 1 | 2012 | 139 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 452 | 0.030 |
Why?
| Genomics | 1 | 2011 | 158 | 0.030 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2009 | 10 | 0.030 |
Why?
| Epitope Mapping | 1 | 2009 | 35 | 0.030 |
Why?
| Logistic Models | 1 | 2012 | 885 | 0.030 |
Why?
| Conserved Sequence | 1 | 2009 | 167 | 0.030 |
Why?
| Medication Adherence | 1 | 2010 | 146 | 0.030 |
Why?
| Silymarin | 1 | 2008 | 2 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2012 | 1543 | 0.020 |
Why?
| Prospective Studies | 1 | 2011 | 1668 | 0.020 |
Why?
| Digestive System Neoplasms | 1 | 2006 | 2 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2009 | 946 | 0.020 |
Why?
| APACHE | 1 | 2006 | 32 | 0.020 |
Why?
| Interviews as Topic | 1 | 2008 | 330 | 0.020 |
Why?
| Morphine | 1 | 2006 | 36 | 0.020 |
Why?
| Patient Selection | 1 | 2008 | 309 | 0.020 |
Why?
| Gastrointestinal Diseases | 1 | 2006 | 61 | 0.020 |
Why?
| Mutation | 1 | 2012 | 1738 | 0.020 |
Why?
| Hydrocortisone | 1 | 2006 | 114 | 0.020 |
Why?
| Graft Rejection | 1 | 2006 | 192 | 0.020 |
Why?
| Double-Blind Method | 1 | 2006 | 489 | 0.020 |
Why?
| Lung Diseases | 1 | 2006 | 107 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2009 | 2049 | 0.020 |
Why?
| Chromans | 1 | 2002 | 9 | 0.020 |
Why?
| Transaminases | 1 | 2002 | 10 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 2002 | 29 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2006 | 560 | 0.010 |
Why?
| Neoplasms | 1 | 2006 | 599 | 0.010 |
Why?
|
|
Szabo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|